Business Context and Reporting Period
This Form 8-K is a Current Report filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in request metadata) on October 13, 2008. The filing reports "Other Events" (Item 8.01) consisting of a press release issued on the same date, which is attached as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to announce the issuance of a press release and does not contain a financial statement or quantitative data.
Material Changes
No material financial changes versus a prior comparable period are detailed in the text of this filing. The document references an external press release for the substance of the event.
Guidance, Outlook, and Risks
The filing does not contain management commentary, guidance, outlook, or specific risk factors within the provided text. It directs readers to the attached press release (Exhibit 99.1) for details regarding the event reported.
Key Facts for Investor Verification
- Verify the content of the press release dated October 13, 2008, attached as Exhibit 99.1, as the filing itself contains no operational details.
- Confirm the company's current legal name and status, noting the discrepancy between the request metadata ("ACHIEVE LIFE SCIENCES, INC.") and the filing header ("ONCOGENEX PHARMACEUTICALS, INC.").
- Check for subsequent filings that may provide financial context related to the event announced in this 8-K.